Kyle J. Savage, Ph.D.
Affiliations: | 2012 | Kinesiology | University of Maryland, College Park, College Park, MD |
Area:
Recreation, Physiological PsychologyGoogle:
"Kyle Savage"Mean distance: 35622
Parents
Sign in to add mentor| Seppo Iso-Ahola | grad student | 2012 | University of Maryland | |
| (Making the cut: Psychological momentum on the PGA tour.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kansara R, Connors JM, Savage KJ, et al. (2016) Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas. Haematologica |
| Schmitz N, Zeynalova S, Nickelsen M, et al. (2016) CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology |
| Moccia AA, Hitz F, Hoskins P, et al. (2016) Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma. Leukemia & Lymphoma. 1-9 |
| Advani RH, Ansell SM, Lechowicz MJ, et al. (2015) A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. British Journal of Haematology |
| Hitz F, Connors JM, Gascoyne RD, et al. (2015) Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment. Annals of Hematology. 94: 1839-43 |
| Hapgood G, Savage KJ. (2015) The biology and management of systemic anaplastic large cell lymphoma. Blood. 126: 17-25 |
| Sun H, Savage KJ, Karsan A, et al. (2015) Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation. Clinical Lymphoma, Myeloma & Leukemia. 15: 341-8 |
| Villa D, George A, Seymour JF, et al. (2014) Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1813-8 |
| Xing KH, Connors JM, Lai A, et al. (2014) Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis. Blood. 123: 3567-73 |
| Mak V, Hamm J, Chhanabhai M, et al. (2013) Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1970-6 |